Lexicon Pharmaceuticals:Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

PrecisionSciencePioneeringMedicinePatientDriven...Weareabiopharmaceuticalcompanywithamissionofpioneeringmedicinesthattransformpatients'lives.。其他文章還包含有:「AboutUs」、「Careers」、「Investors」、「LexiconPharmaceuticals」、「LexiconPharmaceuticals,Inc.(LXRX)StockPrice」、「News」、「Pipeline」

查看更多 離開網站

Provide From Google
About Us
About Us

https://www.lexpharma.com

Corporate Overview. Lexicon Pharmaceuticals is a biopharmaceutical company with a mission of pioneering medicines that transform patients' lives. We are ...

Provide From Google
Careers
Careers

https://www.lexpharma.com

Every job we offer contributes to our profound mission of pioneering medicines that transform patients lives. We are always looking for innovative people ...

Provide From Google
Investors
Investors

https://www.lexpharma.com

Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning ...

Provide From Google
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals

https://en.wikipedia.org

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, ...

Provide From Google
Lexicon Pharmaceuticals, Inc. (LXRX) Stock Price
Lexicon Pharmaceuticals, Inc. (LXRX) Stock Price

https://finance.yahoo.com

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock most popular amongst private equity firms who own 49%, while individual investors hold 25%. Key Insights ...

Provide From Google
News
News

https://www.lexpharma.com

Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference. Jeffrey L. Wade, Lexicon's president and chief ...

Provide From Google
Pipeline
Pipeline

https://www.lexpharma.com

We are commercializing INPEFA ® (sotagliflozin) for the treatment of heart failure. We have also advanced multiple other drug candidates into late-stage ...